trial-designer

Analyze clinical trial designs for comparative analysis across endpoints, populations, and sample size.

Updated May 18, 2026

Search Tags:#design analysis #regulatory compliance #clinical research #clinical trial #protocol comparison

Ready to run

npx skills add https://github.com/DrMoony/PharmaNova --skill trial-designer

💬 Prompt for ChatGPT / Claude Chat▼

Please help me install this Agent Skill.
Skill: trial-designer
Source: https://github.com/DrMoony/PharmaNova/tree/main/.claude/skills/trial-designer
Command: npx skills add https://github.com/DrMoony/PharmaNova --skill trial-designer

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill requires ctgov, openfda, requests, and includes scripts (resource) and references (resource) and assets (resource) components.

What problem does it solve?

This Skill assists in the systematic comparison and analysis of clinical trial design elements between competing trials for the same indication.

Core Features & Use Cases

Systematic Comparison: Compare design elements like endpoint, patient population, duration, comparator, and sample size.
Strategic Analysis: Understand strategic intentions behind design choices.
Regulatory Context: Analyze how design choices align with regulatory guidelines (FDA/EMA).
Data Sources: Utilizes CT.gov v2 API, openFDA, and web searches for in-depth information.

Quick Start

Compare the design of the clinical trial for Drug X between trials 1 and 2.

Frequently Asked Questions about trial-designer

High-intent search queries and answers about installing and using this skill.

FAQPage Schema

How do I compare clinical trial designs for the same indication?▼

To compare clinical trial designs, you analyze design elements like endpoints, patient populations, duration, comparators, and sample size. This Skill systematically compares these elements between competing trials and applies FDA and EMA regulatory guidelines to provide strategic insights.

What is the best way to analyze clinical trial endpoints against regulatory guidelines?▼

The best way to analyze clinical trial endpoints against regulatory guidelines is to evaluate design choices for FDA and EMA compliance. This Skill uses CT.gov v2 API and openFDA data to assess how your trial endpoints and study duration align with current regulatory standards.

Can I use ClinicalTrials.gov data to understand the strategic intentions behind trial design choices?▼

Yes, you can use ClinicalTrials.gov data to understand strategic intentions behind trial design choices. By extracting patient population and comparator data via the CT.gov v2 API, this Skill analyzes the strategic rationale and competitive positioning of competing clinical trials.

Does this clinical trial protocol comparison require access to openFDA and CT.gov APIs?▼

Yes, clinical trial protocol comparison requires access to the CT.gov v2 API and openFDA. These dependencies provide the necessary trial registration data and regulatory context to perform systematic design analysis and protocol comparison.

How do I evaluate sample size and patient population differences between competing trials?▼

To evaluate sample size and patient population differences, you compare the specific design elements extracted from clinical trial records. This Skill processes competing trial data to highlight variations in sample size and population criteria, revealing strategic trial design intentions.